115 related articles for article (PubMed ID: 14702186)
1. Transcription factors involved in development and progression of malignant melanoma.
Poser I; Bosserhoff AK
Histol Histopathol; 2004 Jan; 19(1):173-88. PubMed ID: 14702186
[TBL] [Abstract][Full Text] [Related]
2. [Transcription factors in the development and progression of melanoma].
Lesiak K; Sztiller-Sikorska M; Czyz M
Postepy Hig Med Dosw (Online); 2007 Oct; 61():576-95. PubMed ID: 17971761
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of metastasis-related genes in human melanoma.
Nyormoi O; Bar-Eli M
Clin Exp Metastasis; 2003; 20(3):251-63. PubMed ID: 12741683
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
6. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
Melnikova VO; Dobroff AS; Zigler M; Villares GJ; Braeuer RR; Wang H; Huang L; Bar-Eli M
PLoS One; 2010 Aug; 5(8):e12452. PubMed ID: 20805990
[TBL] [Abstract][Full Text] [Related]
7. Gene regulation in melanoma progression by the AP-2 transcription factor.
Bar-Eli M
Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
9. Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
Tellez C; Bar-Eli M
Oncogene; 2003 May; 22(20):3130-7. PubMed ID: 12789289
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional control of the melanoma malignant phenotype.
Melnikova VO; Bar-Eli M
Cancer Biol Ther; 2008 Jul; 7(7):997-1003. PubMed ID: 18698165
[TBL] [Abstract][Full Text] [Related]
12. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
13. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
14. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.
Eichhoff OM; Weeraratna A; Zipser MC; Denat L; Widmer DS; Xu M; Kriegl L; Kirchner T; Larue L; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Aug; 24(4):631-42. PubMed ID: 21599871
[TBL] [Abstract][Full Text] [Related]
15. Identification of AP-2-regulated genes by macroarray profiling of gene expression in human A375P melanoma.
Suyama E; Minoshima H; Kawasaki H; Taira K
Nucleic Acids Res Suppl; 2002; (2):247-8. PubMed ID: 12903198
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gene expression in melanoma: new approaches for treatment.
Leslie MC; Bar-Eli M
J Cell Biochem; 2005 Jan; 94(1):25-38. PubMed ID: 15523674
[TBL] [Abstract][Full Text] [Related]
17. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
19. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
20. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]